Optical Preclinical Imaging Market To Reach $805.6 Million By 2030

Optical Preclinical Imaging Market Growth & Trends

The global optical preclinical imaging market size is expected to reach USD 805.6 million by the end of 2030, expanding at a CAGR of 4.2%, according to a new report by Grand View Research, Inc.  Increasing number of preclinical studies aimed to study and develop various effective therapeutics for different diseases is a major factor boosting the adoption of optical preclinical imaging systems.

For instance, in December 2018, Bugworks Research, a drug discovery startup based in India, received US$ 3 million grant from CARB-X, a Boston-based organization. The grant was offered to support the development of preclinical trail for novel molecules to fight antimicrobial resistance. Moreover, various researchers are engaged in finding novel ways to increase the reproducibility and robustness of preclinical cancer research with an aim to reduce the failure rate of oncology clinical trials. Optical imaging also allows cost-effective and high-throughput animal study as compared to small animal molecular imaging technologies, including PET and MRI systems.

 Request a free sample copy or view report summary: Optical Preclinical Imaging Market Report

Optical Preclinical Imaging Market Report Highlights

• North America accounted for the largest share in 2024 owing to well-established research infrastructure, adoption of guidelines for preclinical research, product approvals, and higher number of drug development projects

• Based on product type, in the device segment, bioluminescence captured the largest optical preclinical imaging market share in 2024 owing to high sensitivity and broad dynamic range as compared to other techniques for imaging animals used in various studies

• By end use, the pharma and biotech companies segment accounted for the largest optical preclinical imaging market share in 2024 owing to increasing number of candidates in drug development studies and increasing focus on research and development for drug development and innovation

• The research institutes segment is expected to witness the fastest growth during the forecast period owing to rising adoption of advanced optical imaging systems in the research institutes

Optical Preclinical Imaging Market Segmentation

Grand View Research has segmented the global optical preclinical imaging market report based on product, end use, and region:

Optical Preclinical Imaging Product Outlook (Revenue, USD Million, 2018 - 2030)

• Device

  • Fluorescence

  • Bioluminescence

• Consumables

  • Fluorescence

    • Green Fluorescent Proteins

    • Red Fluorescent Proteins

    • Infrared Dyes

    • Others

  • Bioluminescence

    • Luciferins

    • Proluciferins

    • Coelenterazine

    • Others

  • Software

Optical Preclinical Imaging End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharma & Biotech Companies

• Research Institutes

• Others

Optical Preclinical Imaging Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Optical Preclinical Imaging Market

• Bruker

• PerkinElmer

• MR Solutions

• BioTek Instruments, Inc.

• MILabs B.V.

• Magnetic Insight, Inc.

• MBF Bioscience

• FUJIFILM Corporation

• Mediso Ltd.